ID Name Structure References (top 5) Molecular Target(s)
1ID:5823
SEROTONINE


NSC#:92519
Aldrich#:85050
Aldrich#:S012

Freqency:
in 1 ingredients:

  • 14
  • in 34 recipes:

  • 4
  • 6
  • 43
  • 98
  • 114
  • 138
  • 145
  • 150
  • 152
  • 154
  • 165
  • 166
  • 196
  • 206
  • 208
  • 210
  • 219
  • 226
  • 228
  • 231
  • 274
  • 289
  • 320
  • 364
  • 378
  • 415
  • 428
  • 434
  • 445
  • 464
  • 465
  • 519
  • 521
  • 527

  • Properties
    C12H14N2O5    266.25





    1:  Jimenez-Jimenez FJ, Tabernero C, Mena MA, Garcia de Yebenes J, Garcia de Yebenes MJ, Casarejos MJ, Pardo B, Garcia-Agundez JA, Benitez J, Martinez A, et al.
    Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in a model of rat designated a poor metabolizer of debrisoquine.
    J Neurochem.    impact factor:   4.906
    1991;  57(1): 81-7

    2:  Hoepping A, Johnson KM, George C, Flippen-Anderson J, Kozikowski AP.
    Novel conformationally constrained tropane analogues by 6-endo-trig radical cyclization and stille coupling - switch of activity toward the serotonin and/or norepinephrine transporter.
    J Med Chem.    impact factor:   4.079
    2000;  43(10): 2064-71

    3:  Brouillette J, Couture R.
    Evidence for a GABA(B) receptor component in the spinal action of Substance P (SP) on arterial blood pressure in the awake rat.
    Br J Pharmacol.    impact factor:   3.722
    2002;  136(8): 1169-77

    4:  Khalifa M, Daleau P, Turgeon J.
    Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes.
    J Pharmacol Exp Ther.    impact factor:   3.3
    1999;  291(1): 280-4

    5:  Yamada K, Iida R, Miyamoto Y, Saito K, Sekikawa K, Seishima M, Nabeshima T.
    Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-alpha gene: implications for emotional behavior.
    J Neuroimmunol.    impact factor:   3.233
    2000;  111(1-2): 131-8

     
    Time used: 63 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005